Last reviewed · How we verify
NCT03451838
Prediction of Fetal Macrosomia by US
trial testing Ultrasound in Fetal Macrosomia in 102 participants. Status unknown.
5 May 2019
Quick facts
| Lead sponsor | Aljazeera Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 102 |
| Start date | 3 March 2018 |
| Primary completion | 5 May 2019 |
| Estimated completion | 20 June 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Ultrasound
- HbA1c level in blood
Conditions studied
- Fetal Macrosomia — all drugs for Fetal Macrosomia →
Sponsor
Aljazeera Hospital
Who can join
Adults 18 to 43, female only, with Fetal Macrosomia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Fetal macrosomia defined as birth weight above 90th centile ,macrosomia occurs in 42-62%of pregnancy complicated by type 1 diabetes mellitus ,in 30-56% of pregnancy complicated by type 2 diabetes mellitus . -The delivery of macrosomic infant has potentially severe consequence for both the newborn and mother .Increased birth weight increase the risk in the fetus of shoulder dystocia and premature brachial plexus injury ,and those infant weighing above 4500g are at increased risk for neonatal morbidity ,including the need for assisted ventilation and meconium aspiration .Maternal complication result from operative delivery and include postpartum hemorrhage ,third or fourth degree laceration and postpartum infection .
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03451838
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ultrasound
Trials testing the same drug.
- NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
- NCT07505433 — Ultrasound Monitoring of Bone Healing in Ilizarov Bone Transport · not yet recruiting
- NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting
- NCT07342790 — Artificial Intelligence Clinical Decision · NA · not yet recruiting
- NCT07169890 — Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris · NA · completed
Other Aljazeera Hospital trials
Trials by the same sponsor.
- NCT06739759 — Ovarian Hyperstimulation Syndrome Prevention · NA · recruiting
- NCT04778319 — Hysterosalpingography and Hysteroscopy in ICSI · NA · unknown
- NCT04736095 — 3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas · completed
- NCT04749979 — Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin · NA · unknown
- NCT04694677 — Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03451838 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aljazeera Hospital
- Last refreshed: 9 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03451838.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing